ENCO

ENCO: Reports Q3 Results; CEO Expects Breakeven Levels in Late 2009 - 12/01 - 01:55 PM ET

ENCO: Q3 Earnings Call @ 11:00 ET Today [delayed] - 12/01 - 08:20 AM ET

Encorium Announces Receipt of Letter from Nasdaq Regarding its Third Quarter 2008 Form 10-Q Filing - 11/28 - 02:30 PM ET

Encorium Q3 net loss widens - 11/27 - 10:48 AM ET

Encorium Reports Third Quarter 2008 Financial Results - 11/26 - 04:57 PM ET

Encorium signs new business contracts worth $6.5 million - 11/20 - 03:44 AM ET

Encorium Group Inks $6.5 Million Of Contracts - 11/18 - 08:14 PM ET

Encorium Group Signs $6.5 Million of New Business Contracts Mainly Consisting of Oncology Clinical Trials with a U.S. Biopharmaceutical Company - 11/18 - 08:00 AM ET

Encorium Third Quarter 2008 Operating Results on Track, Postpones Filing of 10-Q as it Evaluates Goodwill Impairment Charge - 11/14 - 06:26 PM ET

Encorium Appoints Shahab Fatheazam to its Board of Directors - 11/11 - 08:03 AM ET

ENCORIUM GROUP INC SAYS BOARD OK'S $250,000 STOCK REPURCHASE PROGRAM - 10/06 - 07:53 AM ET

Encorium Announces Stock Buyback; Provides Business and Financial Update - 10/06 - 07:50 AM ET

Encorium Announces Receipt of Nasdaq Letter Regarding Compliance with Nasdaq's Independent Director and Audit Committee Requirements - 10/01 - 04:12 PM ET

Encorium Group Inks $6.2 Million Of Contracts - 09/22 - 03:54 PM ET

ENCO: Signs $6.2 Million of New Contracts for Vaccines Clinical Trials in Europe - 09/22 - 08:39 AM ET

Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials - 09/22 - 07:31 AM ET

Encorium Group names new CEO - 09/11 - 11:07 AM ET

ENCO: Conference call regarding to discuss Changes to the Board of Directors @ 11:00 ET Today [delayed] - 09/11 - 08:20 AM ET

Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors - 09/10 - 05:50 PM ET

Encorium Closes At 10-Year Low - 09/10 - 04:17 PM ET

Page 1 of 5     1  2   3   4   5      Previous  |  Next

<< Back to Stock Index